Effectiveness and Safety of Additive Therapy and Monotherapy of Glaucoma with Prostamides
Increased intraocular pressure (IOP) is the main risk factor for the development of primary open-angle glaucoma (POAG). Nowadays medicine that reduce IOP remain the main method of treating for POAG. The first-line drugs for POAG are prostaglandin analogues. In Russia, for the first time, it appeared...
Saved in:
Main Authors: | I. R. Gazizova, S. R. Zainullina, E. B. Martynova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2019-10-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/1016 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficiency of monotherapy of patients with primary open-angle glaucoma with Bimatoprost 0.03 % (Bimoptic)
by: S. A. Korotkikh, et al.
Published: (2018-12-01) -
Efficacy of bimatoprost sustained-release implant in treating severe intraocular pressure in open glaucoma: A meta-analysis
by: Saad Mutlaq Alosaimi, et al.
Published: (2025-09-01) -
A comparative evaluation of the efficacy and safety of Latanoprost-Optic and Xalatan used as monotherapy and combined with Dorzolamide-Optic for primary open-angle glaucoma under clinical practice conditions
by: D. P. Novikov, et al.
Published: (2023-03-01) -
Changes in the morphofunctional parameters of the eye in neovascular glaucoma on the after vitreoretinal surgery
by: R. R. Fayzrakhmanov, et al.
Published: (2023-10-01) -
The psychology of a glaucoma patient
by: L. M. Gabdrakhmanov, et al.
Published: (2020-09-01)